Learn More
Gibco™ CTS™ Xenon™ Lower Conductivity Electroporation Buffer
Gibco CTS Xenon Lower Conductivity Electroporation Buffer is designed specifically for use with the Xenon Electroporation System.
€ 170.00
Specifications
For Use With (Equipment) | CTS™ Xenon™ Electroporation System |
---|---|
For Use With (Application) | Cell and Gene Therapy Research, Development and Manufacturing |
Shipping Condition | Gel packs |
Volume (Metric) | 100 mL |
Manufacturing Quality | cGMP for Medical Devices, 21 CFR Part 820, and ISO 13485 |
Description
Gibco CTS Xenon Lower Conductivity Electroporation Buffer is designed specifically for use with the Xenon Electroporation System. It is recommended for use with cell types that require higher energy electroporation settings to achieve successful transfection. The formulation helps protect against excessive heat generation during the electroporation process.
Closed-system compatibility
CTS Xenon Lower Conductivity Electroporation Buffer is available in 100-mL bottle and 100-mL bag formats for convenient process development and closed-system manufacturing scale-up.
CTS quality
Gibco CTS products follow USP 'ancillary materials for cell, gene, and tissue-engineered products' within the responsibilities applicable to a supplier.* The products are supplied with harmonized documentation such as intended use statements, certificates of analysis, certificates of origin, and convenient access to our drug master file (DMF). Full documentation traceability is available to support your regulatory filing.
Gibco CTS products are manufactured at a site that uses methods and controls that conform to cGMP for medical devices, 21 CFR Part 820. Our FDA-registered manufacturing sites are ISO 13485-certified.
*Other aspects of USP will be the responsibility of the end user to assess. Thermo Fisher Scientific cannot fulfill USP in regard to application and therapy-specific aspects (e.g., residual assessment and removal of the AM).
Specifications
CTS™ Xenon™ Electroporation System | |
Gel packs | |
cGMP for Medical Devices, 21 CFR Part 820, and ISO 13485 |
Cell and Gene Therapy Research, Development and Manufacturing | |
100 mL |
Safety and Handling
missing translation for 'shelfLife' : 12 months from date of manufacture
For Research Use or Manufacturing of Cell, Gene, or Tissue-Based Products. CAUTION: Not intended for direct administration into humans or animals.